deltatrials
Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT00888290

Sodium Bicarbonate Supplementation in Chronic Kidney Disease Evaluation of Dose Response, Safety and Beneficial Effects

Sponsor: Albert Einstein College of Medicine

Conditions Chronic Kidney Disease
Interventions Placebos Sodium bicarbonate
Updated 11 times since 2017 Last updated: Aug 12, 2022 Started: Mar 31, 2009 Primary completion: May 31, 2010 Completion: May 31, 2010
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00888290, this PHASE2/PHASE3 trial focuses on Chronic Kidney Disease and remains completed. Sponsored by Albert Einstein College of Medicine, it has been updated 11 times since 2009, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Feb 2019 · 8 months · monthly snapshotCompleted~Feb 2019 – ~Jan 2021 · 23 months · monthly snapshotCompleted~Jan 2021 – ~Sep 2022 · 20 months · monthly snapshotCompleted~Sep 2022 – ~Dec 2022 · 3 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 9 months · monthly snapshotCompleted

Change History

11 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2/PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2/PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2/PHASE3

    Phase: PHASE2_PHASE3 → PHASE2/PHASE3

  4. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE2_PHASE3

  5. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE2_PHASE3

▶ Show 6 earlier versions

  1. Sep 2022 — Dec 2022 [monthly]

    Completed PHASE2_PHASE3

  2. Jan 2021 — Sep 2022 [monthly]

    Completed PHASE2_PHASE3

  3. Feb 2019 — Jan 2021 [monthly]

    Completed PHASE2_PHASE3

  4. Jun 2018 — Feb 2019 [monthly]

    Completed PHASE2_PHASE3

  5. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE2_PHASE3

  6. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE2_PHASE3

    First recorded

Mar 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Albert Einstein College of Medicine
Data source: Albert Einstein College of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations